chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 infection; COVID 19 infection; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EN6207), as dose 2, single (Lot number: ER8734) and on 12Nov2021 as dose 3 (booster), single (Lot number: FD0809) at the age of 40 years for covid-19 immunisation. The patient's relevant medical history included: "sinus pressure" (unspecified if ongoing), notes: sinus pressure due to COVID 19 returned. Concomitant medication(s) included: MONTELUKAST; LOW-OGESTREL; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; EXCEDRIN MIGRAINE; BUDESONIDE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Jul2022, outcome "recovered" (19Jul2022) and all described as "COVID 19 infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Jul2022) Positive, notes: Last positive test taken was 18Jul2022; (24Jul2022) Negative, notes: I tested negative for COVID 19 24Jul2022. Therapeutic measures were taken as a result of covid-19.  Clinical course: Current age: 40 years. Other medication details. Other medication in 2 weeks product: Montelukast, Low-Ogestrel, Budesonide, Nexium, Excedrine Migraine. Adverse event: 4 days after completing the Paxlovid antiviral my sinus pressure due to COVID 19 returned. I continued to test positive from the completion of the antiviral to the return of symptoms. I took over the counter medication to alleviate symptoms, and I tested negative for COVID 19 24Jul2022. Last positive test taken was 18Jul2022. Adverse event start date: 15Jul2022, If patient recovered: recovered. Adverse event stop date: 19Jul2022   No follow-up attempts are possible. No further information is expected.
Mass; contusion, rash, fever - information has been received from a family member concerning a 23  month old male who on 04 Apr 2000 was vaccinated with one dose of varicella virus vaccine live in the arm.  on 08 Apr 2000 the patient devloped a 2X3 inch lesion on his inner thigh and he had a fever 100.2 F.  The patient was taken to the emergency room for evaluation.  It was noted that the patient had signs of infection and that a white blood cell count was elevated.  On 09 apr 2000 the patient's lesions were noted as oozing and surrounded by little bruised that went all the way up the length of his leg to his buttocks.  On 10 apr 2000 the patient had a rash on his face on 10 lesions and only some of them looked like chickenpox.  Additional information has been requested.
Not feeling well for the first week and pain in shoulder and arm. On 2/20 I noticed tenderness in arm pit. On 2/24 I noticed a lump in my arm pit along with increased tenderness.  The lump was large enough that I could feel it with my arm down. On 2/24 I made an appointment with my health care provider.  I was given an antibiotic ( Clindamycin 300 mg) to take for 10 days for pain and swelling . On 3/3  I notice the symptoms had not improved and tenderness had progressed down my arm to the elbow area and also into the back of my shoulder from the arm pit area.
Right away I started to feel very hot. I waited the time (15 minutes) they recomemnded to stay at pharmacy. I drove home and started to feel nausea, a light headache, and mildly dizzy. I started to get short of breath about 45 to 50 minutes after the injection. I climbed a flight of stairs and was completely winded I was having trouble catching my breath. My lymph nodes in my neck swelled up a lot and I was developing a sore throat and small bumps on roof of mouth. I called the nurses line and was directed to take a 50 mcg dose of benadryl and that if the shortness got worse to call 911 and use my epi pen.  After about 2.5 hours the breathing seemed to primarily resolve itself and resume more normally. I woke up this morning with a very sore arm, body aches, a mild headache, congested sinuses, and with a sore throat. I do feel like I am not tasting as well as normal, it could be the congestion. I do not feel great but only seem mildly winded and short of breath walking across the house.
Patient states sore & inflamed right arm & was given Cephalexin 500 mg QID x 10 days. All happened within 24 hours.
Developed high fever; rash; lethargic; blank staring; would not coo or babble. Would not look at me. Over a period of several months, my child appeared to regress. He stopped meeting normal developmental milestones. Diagnosis-pervasive developmental disorder per MD.
Swelling and redness up to left shoulder by evening on day vaccine was given.  Was warm to touch and painful. Applied ice, took oral Benadryl. Had decreased swelling and pain 24 hours after treating
1 of 2 pts vaxed in SEP93 who exp the flu (type A & B) in DEC93;pt recovered;no further clinical details available
Patient received #2 COVID-19 vaccine 1/12/21 and slept through the night.  When she was standing at the kitchen sink making breakfast at 10:00 am on 1/13/21 she fainted and woke up on the floor.  Her child stated that she had fallen to the floor.  She did not hit her head.  Patient had an appointment to see her PCP the following day concerning something else.  She did relay this information to her PCP who is asking that she follow up with a cardiologist.  The PCP had no opinion if the vaccine may have caused her syncope.  She currently has a appointment with a cardiologist.
This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (I have tested positive for COVID a couple of days after the shot) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. Concomitant products included PREDNISONE, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), METHOTREXATE, ALENDRONATE SODIUM and GABAPENTIN for an unknown indication. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (I have tested positive for COVID a couple of days after the shot). At the time of the report, SARS-COV-2 TEST POSITIVE (I have tested positive for COVID a couple of days after the shot) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Other relevant concomitant medications included Noxafil Possaconazole, Timolol eye drops, Prednisone eye drops and OTC multivitamin. No treatment information was provided.
Tired, thirsty. Flushing/sweating - BP119/68 (pulse 65).
Mild chills; Feel tired; This is a spontaneous report from a contactable consumer or other non hcp. A 87-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 01Jun2021 (at the age of 87-years-old) (Batch/Lot Number: EW0185) as single dose for covid-19 immunisation. Medical history included ongoing high blood pressure (10 years ago), ongoing anxiety (2 years ago), ongoing atrial fibrillation and hip surgery from an unknown date and unknown if ongoing (few years ago). The patient did not emergency room and physician office visit. Prior Vaccinations (within 4 weeks): None. Concomitant medication included warfarin taken for atrial fibrillation, start and stop date were not reported; olmesartan medoxomil (BENICAR) taken for blood pressure, start and stop date were not reported; nebivolol hydrochloride (BYSTOLIC) taken for blood pressure start and stop date were not reported; diltiazem hydrochloride (DILTIAZEM CD) taken for blood pressure, start and stop date were not reported; clonazepam taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 on 04May2021 (Batch/lot number EW017) administered in, Left arm for covid-19 immunisation and experienced tired. The patient previously took Flu shot and experienced Sort of bothered my face (40-50 years ago). The reporter stated that second dose received 28 days after first dose. she had her second dose of the Pfizer COVID-19 vaccine 01Jun2021 and on 03Jun2021 started to feel tired she is stating to feel better. she didn't have a sore arm or anything and that the Covid-19 vaccine didn't seem to bother her. She stated she did notice having chills but realized it was because she had her air conditioning too high and was cold from the air temperature, does not think she had a fever. The patient experienced mild chills on 04Jun2021, but she was no longer having. Relevant tests was none. The outcome of the events feel tired was reported as recovering and mild chills was reported as recovered on 04Jun2021.   Follow-up attempts are completed. No further information is expected.
No adverse events reported. COVID card documentation shows Pfizer was given.  Unable to determine definitively which vaccine was given.
Two weeks after vaccine my right thumb to my wrist were swollen and sore. I could not make a fist. I took ibuprofen and wore a compression glove. Pain subsided some. Two weeks later I had pain in my left pointer finger and knuckle. Family doctor said I may have RA so she had me do blood work. Result showed RA so I made appointment with RA doctor. Flew before visit with RA doctor. My left ankle hurt when I got off the plane. It was swollen and sore by the end of the night and so was my left wrist.
My arm was red and raised and hot directly at injection site at first.  Then hotness went away the next day but was still raised up and red about the size of a silver dollar.  After a couple of days, it was slightly itchy too. Today marks 2 weeks and I still have an small egg shaped red mark just slightly raised on my left arm at injection site that at times seems itchy. It is not bothersome at all, but I felt like you would want to know.
(R) deltoid site reaction, 2 in red area of swelling, nausea, advised to take ibuprofen, Rx REGLAN for nausea. Advised time off work, call with persistent symptoms. Apply ice for swelling and discomfort.
Died of COVID-19 illness on 06/14/2021  Immediate Cause of Death: Acute respiratory distress syndrome with respiratory failure Due To or as a Consequence Of: COVID-19 infection Interval between Onset & Death: 4 days  COD listed as ACUTE RESPIRATORY DISTRESS SYNDROME WITH RESPIRATORY FAILURE INTERVAL BETWEEN ONSET & DEATH and COVID-19 INFECTION INTERVAL BETWEEN ONSET & DEATH
The immunizations were given in her Right arm on 9/29/2017 (the FLUZONE top right and PNEUMOVAX bottom right arm). The patient woke up the morning of 9/30/2017 and states her arm was swollen to twice its size from her shoulder to her elbow. Her arm was red and hot to the touch. Then shortly after she experienced fever/ chills and started vomiting. Patient states these symptoms lasted for 5 days. I spoke with her today and she is doing good.
This spontaneous report as received from a registered nurse on 15-OCT-2014 concerning an unspecified number of patients. On an unknown date the patients was vaccinated with VAQTA (route, dose was unknown) which was improperly stored. No adverse effects reported. No product quality complaint was involved. It was reported that this case was opened on 26-AUG-2014 for temperature inquiry only. The outcome of the events was unknown. This case is linked to cases MARRS # 1410USA008635, 1410USA013361, 1410USA013360, 1410USA013359 with the same reporter link. Additional information is not expected.
Arm  became  hot and feverish.    Arm  became  swollen.   Arm  was throbbing and  continuously  itchy.   There  was  raised  spots on  arm. Could  not  sleep  at  night.    lasted  for about  a week.    My concern  is  with  the affect  of the SECOND  shot  that I might  experience
Eight hours after vaccination my temperature started to climb. At 100.8 I took two Tylenol it continued to climb to 101.4. After two hours at 101.4 I started sweating and my temperature decreased to 100.8 for several more hours. Then decreased to 99.8
Influenza virus vaccine Fluzone injection 0.5ml IM in left lateral deltoid. Noted in morning a 6cm in circumference, warm and firm in center, tender to touch. No treatments, Continues to fade.
Moderns covid-19 vaccine EUA Migraine Shortness of breath Joint pain fever Runny nose Cough with phlegm Extreme fatigue
Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, SARS-CoV-2 test: Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
First dizzy spell went away after a few minutes, when it happened a second time at work the school nurse took my BP it was extremely high, she wanted to send me to hospital, I went to see my doctor, they did an EKG she put me on hydrochlorothiazide, my heart rate continued to remain high so the doctor switched my medicine to amlodipine besylate, I'm still on that medication My BP has stayed relatively stable on cusp between normal to stage 1. My heart rate has been normal on medicine.
Left arm is swollen and red, 48 hrs. post vaccination, site of redness seems to have grown, painful - has increased since day of administration.
Red, raised , itchy welt appeared on arm 1 week and 1 day after the injection.
mouth blisters; itching at vaccination site; redness that is expanding; hardness at vaccination site; bumps and whelps around injection site; Glucose high; Blood pressure levels jumps very high (2-40 increase in numbers); welts; heart rate increased; pain at vaccination site; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Mar-2021. The most recent information was received on 31-Mar-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at vaccination site), VACCINATION SITE PRURITUS (itching at vaccination site), VACCINATION SITE ERYTHEMA (redness that is expanding), VACCINATION SITE INDURATION (hardness at vaccination site) and SWELLING (bumps and whelps around injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at vaccination site), BLOOD GLUCOSE INCREASED (Glucose high), HYPERTENSION (Blood pressure levels jumps very high (2-40 increase in numbers)), URTICARIA (welts) and HEART RATE INCREASED (heart rate increased). On 17-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching at vaccination site), VACCINATION SITE ERYTHEMA (redness that is expanding), VACCINATION SITE INDURATION (hardness at vaccination site) and SWELLING (bumps and whelps around injection site). On an unknown date, the patient experienced BLISTER (mouth blisters). At the time of the report, VACCINATION SITE PAIN (pain at vaccination site), VACCINATION SITE PRURITUS (itching at vaccination site), VACCINATION SITE ERYTHEMA (redness that is expanding), VACCINATION SITE INDURATION (hardness at vaccination site), SWELLING (bumps and whelps around injection site), BLOOD GLUCOSE INCREASED (Glucose high), HYPERTENSION (Blood pressure levels jumps very high (2-40 increase in numbers)), BLISTER (mouth blisters), URTICARIA (welts) and HEART RATE INCREASED (heart rate increased) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included OTC Hydrocortisone 1% spray, and ice pack   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Significant follow up appended On 12-Apr-2021: NonSignificant follow up appended
Pt received vaccine 8/28. Presented to pharmacy 8/29 in PM - large, red, raised rash at injection site approx. 1 1/2 inches wide x 4 inches long. No fever. Painful and had gotten slightly worse.
Hospitalized 2/20/22-2/25/22 Fall, decreased left side hemiplegia, forehead hematoma, stroke, a-fib, cough, SOB, dyspnea, PNA, sepsis,
Diarrhea; A spontaneous report was received from a nurse on 28SEP2023 regarding a 62-year-old female patient who had "diarrhea" (PT: Diarrhoea) following the administration of oral Vivotif capsules (typhoid vaccine live oral Ty21A; lot number: unknown) for immunisation.  The patient's medical history, concomitant medications, or allergies were not reported.  On 12SEP2023, the patient took the first dose of Vivotif followed by the second dose on 14SEP2023 and the third on 16SEP2023. On 18SEP2023, the last day of administration, the patient had diarrhea about every 30 minutes before taking the dose and still she took the last dose on the same day. After taking the dose the patient again had diarrhea and did not have any vomiting.  The outcome of the reported event was unknown, at the time of this report.  No action was taken with Vivotif with respect to the reported event.  No additional information was reported.  Significant follow-up information was received from the nurse on 11OCT2023.  The patient's medical history included stomach ulcers (patient was not sure whether she had stomach ulcers or not), cystic COVID infection, "unknown" gastric bloating and allergies included hay fever. Reportedly, the patient recovered from COVID Infection.  Her concomitant medications included progesterone, omeprazole, skin vitamins, hairs and nails vitamins, vitamin C (ascorbic acid), calcium, and L-carnitine. (levocarnitine).  It was reported that the patient did not take any treatment for diarrhea.  It was updated that the patient recovered from the reported event on an unknown date in 2023.  Company comment: It was reported that a female consumer received Vivotif for immunisation and on the day of the fourth dose, the patient had diarrhea (diarrhoea) before taking the dose and still she took the dose after which she again had diarrhea. She had recovered from the reported event. Considering the case information, the role of Vivotif cannot be ruled out and the causality of diarrhoea is assessed as possible. The case is considered non-serious as per medical assessment.; Sender's Comments: It was reported that a female consumer received Vivotif for immunisation and on the day of the fourth dose, the patient had diarrhea (diarrhoea) before taking the dose and still she took the dose after which she again had diarrhea. She had recovered from the reported event. Considering the case information, the role of Vivotif cannot be ruled out and the causality of diarrhoea is assessed as possible. The case is considered non-serious as per medical assessment.
No adverse effect; Patient was vaccinated with improperly stored dose of VAQTA; This spontaneous report was received from a vaccine administrator referring a patient of unknown gender and age. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not provided.  On 09-JUL-2019, the patient was vaccinated for prophylaxis with improperly stored dose of Hepatitis A Vaccine, Inactivated (VAQTA) (lot number: S002460 and expiration date: 15-MAY-2020; lot number: R034340 and expiration date: 23-NOV-2019, dosage schedule, route and anatomical location were not reported) (lot number R023606 is an invalid lot number for Hepatitis A Vaccine, Inactivated (VAQTA)).  The temperature was 49.3 degrees fahrenheit (F) for a time frame of 4 hours and 30 minutes, without a previous temperature excursion and was call because a digital data logger. No further information was available.
Starting 2 days post vaccine she experienced a series of mild seizures and headaches/dizziness. Her provider temporarily increased her dose Topamax which led to improvement of symptoms.
2 weeks, post vax of varicella vaccine, pt broke out in red, raised area on abdomen and back with itching. Recommended Benadryl and Caladryl.
Pain at the injection site; Body aches; Low grade fever; Chills; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration in the left shoulder area, on 03Feb2021, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included multivitamin, losartan, eye vitamin and Garlic. The patient previously received first dose of BNT162B2 (lot number: EL3248) on 13Jan2021 for COVID-19 immunization. On an unspecified date, the patient experienced pain at the injection site, body aches, low grade fever, and chills. The patient took ibuprofen as treatment. The events did not require emergency room/ physician visit. Outcome of the events was unknown.
Information has been received from a female consumer (age not reported) with diabetes and a history of high blood pressure who was vaccinated with a dose of Zostavax. Subsequently the patient experienced pain and headache. The patient sought unspecified medical attention. The patient recovered. There was no product quality complaint. No further information is available.
Pfizer-BioNTech COVID-19 Vaccine, Bivalent EUA Sore arm for 24 hours. Fever of 99.5 and headache started apx 20 hours post vaccine administration and was successfully treated with one 500 mg acetaminophen dose.
Chills, fever,body aches, fatigue, headache, sweating, slight loss of taste
DATE: 02/20/21 12:00AM - AWOKE WITH SEVERE ITCHING ON WRIST OF BOTH ARMS 12:00 - 12:45AM - STAYED AWAKE WHILE IN BED ITCHING BOTH ARMS 12:45AM - WENT TO BATHROOM TO A VISUAL VIEW OF ITCHING ARM. BOTH ARMS, WRIST TO ELBOWL, WERE EXTREMLY RED "RED" DOTS OVER WHOLE BODY FROM THE THROAT DOWN; NO SPOTS OR REDNESS ON THE HEAD OR FACE. SLIGHT PRESSURE ON CHEST. APPLIED CERAVE LOTION ON MULTIPLE AREAS OF THE BODY, WHICH PROVIDED INSTANT RELIEF. DRANK A CUP OF BIGELOW MATCHA GREEN TEA WITH TURMERIC. WEN TO BED AT 02:00AM UNTIL 07:30AM. ALL PROMBLES ABOVE WERE GONE. SKIN LOOKED  THE SAME AS LAST EVENING  AT BEDTIME 10:30PM.